HW
ABBV icon

HORAN Wealth’s AbbVie ABBV Stock Holding History

HORAN Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.44M Buy
25,603
+522
+2% +$112K 0.53% 40
2026
Q1 		$5.51M Buy
25,081
+414
+2% +$91.8K 0.52% 40
2025
Q4 		$5.64M Buy
24,667
+317
+1% +$72.2K 0.87% 23
2025
Q3 		$5.64M Buy
24,350
+8,313
+52% +$1.69M 0.89% 21
2025
Q2 		$2.98M Buy
+16,037
New +$2.98M 0.91% 37

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HORAN Wealth's ABBV Position: Q2 2026 in Review

HORAN Wealth increased its AbbVie (ABBV) stake by 2.1% in Q2 2026, buying an estimated $112K and bringing the position to 25,603 shares worth $6.44M. The position accounts for 0.53% of the portfolio, ranked #40.

HORAN Wealth first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HORAN Wealth held 25,603 shares of AbbVie worth $6.44M as of Q2 2026.
  • HORAN Wealth bought 522 AbbVie shares in Q2 2026, an estimated $112K.
  • AbbVie made up 0.53% of HORAN Wealth's portfolio in Q2 2026, its #40 holding.
  • HORAN Wealth first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HORAN Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.